AP AlzeCure Pharma AB Stock: price and management transactions · Finland · FIN-FSASource id FI:alzecure-pharma-ab ISIN ISIN SE0028850099FI · FIN-FSA Mcap SEK 798.2M 医疗保健 Follow the AlzeCure Pharma AB share price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, AlzeCure Pharma AB has logged 10 insider filings. Market capitalisation: €798.2m. The latest transaction was filed on 4 July 2026 (Purchase). Among the most active insiders: Martin Jönsson. The full history is openly available.
€303,442
10 ops.
Buy Volume
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 July 2026
All Executives10 Thresholds0 Prospectus0 Other0
Declarations 10 total
● Verkställande direktör (VD) · Executives · 2 Jul 2026
184,914 shares @ SEK 1.31 0.027% mcap 93.2% of flow BTA (betald tecknad aktie) ISIN ISIN SE0028850099FI:csv-cd6e11af1a52c2985dd2 ● Styrelseordförande · Executives · 30 Jun 2026
327,406 shares @ SEK 1.31 0.0080% mcap 100.0% of flow BTA (betald tecknad aktie) ISIN ISIN SE0028850099FI:csv-59693ac2b9bb4637ea6c ● Styrelseordförande · Executives · 30 Jun 2026
240,625 shares @ SEK 1.31 0.0059% mcap 20.2% of flow BTA (betald tecknad aktie) ISIN ISIN SE0028850099FI:csv-a68983a62b35da41f27c ● Annan ledande befattningshavare · Executives · 1 Jul 2026
194,940 shares @ SEK 1.31 0.0048% mcap 100.0% of flow BTA (betald tecknad aktie) ISIN ISIN SE0028850099FI:csv-ae89b39d48641cfdae04 ● Annan medlem i bolagets administrations-, lednings- eller kontrollorgan · Executives · 26 Jun 2026
177,275 shares @ SEK 1.31 0.0044% mcap 100.0% of flow BTA (betald tecknad aktie) ISIN ISIN SE0028798975FI:csv-ece03a7e2fc9302981e3 ● Verkställande direktör (VD) · Executives · 25 Aug 2025
8,067 shares @ €0.1965 0.0010% mcap 100.0% of flow Aktie ISIN ISIN SE0025399124FI:A003R766-1 ● Annan medlem i bolagets administrations-, lednings- eller kontrollorgan · Executives · 30 Jul 2025
55,624 shares @ €0.1967 0.0068% mcap 100.0% of flow BTA (betald tecknad aktie) ISIN ISIN SE0025399132FI:A003R199-1 ● Styrelseledamot · Executives · 24 Jul 2025
150,000 shares @ €0.1963 0.018% mcap 100.0% of flow BTA (betald tecknad aktie) ISIN ISIN SE0010133785FI:A003R169-1 ● Styrelseordförande · Executives · 23 Jul 2025
568,030 shares @ €0.1965 0.070% mcap 100.0% of flow BTA (betald tecknad aktie) ISIN ISIN SE0010133785FI:A003R016-1 ● Annan medlem i bolagets administrations-, lednings- eller kontrollorgan · Executives · 19 Jan 2021
20,000 shares @ SEK 8.97 100.0% of flow Aktie ISIN ISIN SE0010133785FI:A001P627-1 关于 AlzeCure Pharma AB AlzeCure Pharma AB 是一家生物制药公司，专注于开发神经退行性疾病，特别是阿尔茨海默病的治疗方法。该公司在 XSTO 市场上市。